APA

Böll B., Plütschow A., Bürkle C., Atta J., Pfreundschuh M., Feuring-Buske M., Vogelhuber M., Sökler M., Eichenauer D. A., Thielen I., von Tresckow B., Fuchs M., Engert A. & Borchmann P. (20200219). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. : British journal of haematology.

Chicago

Böll Boris, Plütschow Annette, Bürkle Carolin, Atta Johannes, Pfreundschuh Michael, Feuring-Buske Michaela, Vogelhuber Martin, Sökler Martin, Eichenauer Dennis A, Thielen Indra, von Tresckow Bastian, Fuchs Michael, Engert Andreas and Borchmann Peter. 20200219. Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. : British journal of haematology.

Harvard

Böll B., Plütschow A., Bürkle C., Atta J., Pfreundschuh M., Feuring-Buske M., Vogelhuber M., Sökler M., Eichenauer D. A., Thielen I., von Tresckow B., Fuchs M., Engert A. and Borchmann P. (20200219). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. : British journal of haematology.

MLA

Böll Boris, Plütschow Annette, Bürkle Carolin, Atta Johannes, Pfreundschuh Michael, Feuring-Buske Michaela, Vogelhuber Martin, Sökler Martin, Eichenauer Dennis A, Thielen Indra, von Tresckow Bastian, Fuchs Michael, Engert Andreas and Borchmann Peter. Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. : British journal of haematology. 20200219.